2,3-Aziridino-2,3-dideoxy-D-ribono-γ-lactone 5-Phosphonate: Stereocontrolled Synthesis from D-Lyxose and Unusual Aziridine Ring Opening

Journal of Organic Chemistry

Volumn 62, Issue 13, 1997, Pages 4277-4284

  Dauban, Philippe ^a   Dodd, Robert H ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 AZIRIDINO 2,3 DIDEOXYRIBONOLACTONE 5 PHOSPHONIC ACID; AZIRIDINE DERIVATIVE; N (BENZYLOXYCARBONYL) 4 (DIETHOXYPHOSPHINYL)METHYL 3 OXA 6 AZABICYCLO[3.1.0]HEXAN 2 ONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; HYDROLYSIS; NEUROLOGIC DISEASE; STEREOCHEMISTRY; SYNTHESIS;

EID: 0030861232     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9623494     Document Type: Article

References (36)

1. For reviews, see: Watkins, J. C.; Krogsgaard-Larsen, P.; Honoré, T. Trends Pharmacol. Sci. 1990, 11, 25. Nakanishi, S. Science 1992, 258, 597. Bigge, C. F. Biochem. Pharmacol. 1993, 45, 1547. Kalb, R. G. Neuroscientist 1995, 1, 60.
2. For reviews, see: Watkins, J. C.; Krogsgaard-Larsen, P.; Honoré, T. Trends Pharmacol. Sci. 1990, 11, 25. Nakanishi, S. Science 1992, 258, 597. Bigge, C. F. Biochem. Pharmacol. 1993, 45, 1547. Kalb, R. G. Neuroscientist 1995, 1, 60.
3. For reviews, see: Watkins, J. C.; Krogsgaard-Larsen, P.; Honoré, T. Trends Pharmacol. Sci. 1990, 11, 25. Nakanishi, S. Science 1992, 258, 597. Bigge, C. F. Biochem. Pharmacol. 1993, 45, 1547. Kalb, R. G. Neuroscientist 1995, 1, 60.
4. For reviews, see: Watkins, J. C.; Krogsgaard-Larsen, P.; Honoré, T. Trends Pharmacol. Sci. 1990, 11, 25. Nakanishi, S. Science 1992, 258, 597. Bigge, C. F. Biochem. Pharmacol. 1993, 45, 1547. Kalb, R. G. Neuroscientist 1995, 1, 60.
5. Watkins, J. C. In The NMDA Receptor; Watkins, J. C., Collingridge, G. L., Eds.; IRL Press at Oxford University Press: Oxford, 1989.
6. Li, J.-H.; Bigge, C. F.; Williamson, R. M.; Borosky, S. A.; Vartanian, M. G.; Ortwine, D. F. J. Med. Chem. 1995, 38, 1955 and references therein.
7. Evans, R. H.; Francis, A. A.; Jones, A. W.; Smith, D. A. S.; Watkins, J. C. Br. J. Pharmacol. 1982, 75, 65.
8. Meldrum, B. S.; Croucher, M. J.; Czuczwar, S. J.; Collins, J. F.; Curry, K.; Joseph, M.; Stone, T. W. Neuroscience 1983, 9, 925. Lehmann, J.; Schneider, J.; McPherson, S.; Murphy, D. E.; Bernard, P.; Tsai, C.; Bennett, D. A.; Pastor, G.; Steel, D. J.; Boehm, C.; Cheney, D. L.; Liebman, J. M.; Williams, M.; Wood, P. L. J. Pharmacol. Exp. Ther. 1987, 240, 737.
9. Meldrum, B. S.; Croucher, M. J.; Czuczwar, S. J.; Collins, J. F.; Curry, K.; Joseph, M.; Stone, T. W. Neuroscience 1983, 9, 925. Lehmann, J.; Schneider, J.; McPherson, S.; Murphy, D. E.; Bernard, P.; Tsai, C.; Bennett, D. A.; Pastor, G.; Steel, D. J.; Boehm, C.; Cheney, D. L.; Liebman, J. M.; Williams, M.; Wood, P. L. J. Pharmacol. Exp. Ther. 1987, 240, 737.
10. Fagg, G. E.; Olpe, H.-R.; Pozza, M. F.; Baud, J.; Steinmann, M.; Schmutz, M.; Portet, C.; Baumann, P.; Thedinga, K.; Bittiger, H.; Allgeier, H.; Heckendorn, R.; Angst, C.; Brundish, D.; Dingwall, J. G. Br. J. Pharmacol. 1990, 99, 791.
11. Sills, M. A.; Fagg, G.; Pozza, M.; Angst, C.; Brundish, D. E.; Hurt, S. D.; Wilusz, E. J.; Williams, M. Eur. J. Pharmacol. 1991, 192, 19.
12. Lehmann, J.; Hutchinson, A. J.; McPherson, S. E.; Mondadori, C.; Schmutz, M.; Sinton, C. M.; Tsai, C.; Murphy, D. E.; Steel, D. J.; Williams, M.; Cheney, D. L.; Wood, P. L. J. Pharmacol. Exp. Ther. 1988, 246, 65.
13. Whitten, J. P.; Muench, D.; Cube, R. V.; Nyce, P. L.; Baron, B. M.; McDonald, I. A. Bioorg. Med. Chem. Lett. 1991, 1, 441.
14. Bigge, C. F.; Wu, J.-P.; Drummond, J. T.; Coughenour, L. L.; Hanchin, C. M. Bioorg. Med. Chem. Lett. 1992, 2, 207.
15. Whitten, J. P.; Cube, R. V.; Baron, B. M.; McDonald, I. A. Bioorg. Med. Chem. Lett. 1993, 3, 19.
16. Ornstein, P. L.; Schaus, J. M.; Chambers, J. W.; Huser, D. L.; Leander, J. D.; Wong, D. T.; Paschal, J. W.; Jones, N. D.; Deeter, J. B. J. Med. Chem. 1989, 32, 827.
17. Whitten, J. P.; Baron, B. M.; Muench, D.; Miller, F.; White, H. S.; McDonald, I. A. J. Med. Chem. 1990, 33, 2961.
18. Whitten, J. P.; Baron, B. M.; McDonald, I. A. Bioorg. Med. Chem. Lett. 1993, 3, 23.
19. Rudisill, D. E.; Whitten, J. P. Synthesis 1994, 851.
20. Dauban, P.; Chiaroni, A.; Riche, C.; Dodd, R. H. J. Org. Chem. 1996, 61, 2488.
21. Dubois, L.; Mehta, A.; Tourette, E.; Dodd, R. H. J. Org. Chem. 1994, 59, 434.
22. Dauban, P.; Dubois, L.; Tran Huu Dau, E.; Dodd, R. H. J. Org. Chem. 1995, 60, 2035.
23. Parikh, J. R.; Wolff, M. E.; Burger, A. J. Am. Chem. Soc. 1957, 79, 2778.
24. Yamamoto, H.; Harada, M.; Inokawa, S.; Seo, K.; Armour, M.-A.; Nakashima, T. Carbohydr. Res. 1984, 127, 35.
25. Lerner, L. M. Carbohydr. Res. 1977, 53, 177.
26. Garegg, P. J.; Samuelsson, B. J. Chem. Soc., Perkin Trans, 1 1980, 2866.
27. Szarek, W. A.; Zamojski, A.; Tiwari, K. N.; Ison, E. R. Tetrahedron Lett. 1986, 27, 3827.
28. Adapted from the procedure for the preparation of the ribo analogue of 6: Levene, P. A.; Stiller, E. T. J. Biol. Chem. 1934, 104, 299.
29. Dubois, L.; Dodd, R. H. Tetrahedron 1993, 49, 901.
30. Guiller, A.; Gagnieu, C. H.; Pacheco, H. Tetrahedron Lett. 1985, 26, 6343.
31. Lohray, B. B. Synthesis 1992, 1035.
32. Gao, Y.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 7538.
33. Carlsen, P. H. J.; Katsuki, T.; Martin, V. S.; Sharpless, K. B. J. Org. Chem. 1981, 46, 3936.
34. For a review, see: Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P. Synthesis 1994, 639.
35. N2 nucleophilic opening of the aziridine ring at C-3, to give the trans-2-amino-3-alkoxybutyro-lactone derivative, with no participation by the C-5 phosphonate group. Details of this work will be published elsewhere.
36. Although unusual, this intramolecular aziridine ring opening is not entirely unprecedented since Ho and co-workers have described such a reaction with a benzyl ester group or a carboxamide. Ho, M.; Chung, J. K. K.; Tang, N. Tetrahedron Lett. 1993, 34, 6513.